What is Novavax's earnings yield?

Novavax (NVAX) reported earnings yield of -6.6% in Q1 2026.

How has Novavax's earnings yield changed year-over-year?

Novavax's earnings yield decreased by 114.3% year-over-year, from 46.4% to -6.6%.

What is the long-term trend for Novavax's earnings yield?

Over 5 years (2020 to 2025), Novavax's earnings yield has grown at a 52.1% compound annual growth rate (CAGR), from -5% to 40.3%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Novavax NVAX Earnings yield

Earnings yield at other companies

ModernaMRNA

-15.9%-5.2pp

Roivant SciencesROIV

-5.4%-5.8pp

Merck & Co.MRK

3%-4.7pp

Vaxcyte, Inc.PCVX

-11.3%+1.0pp

Viridian Therapeutics, Inc.VRDN

-18%-4.7pp

ALN

Alnylam PharmaceuticalsALNY

1.1%+0.8pp

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

net income/market cap=-6.6%

Based on trailing twelve months.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's earnings yield?: Novavax (NVAX) reported earnings yield of -6.6% in Q1 2026.
How has Novavax's earnings yield changed year-over-year?: Novavax's earnings yield decreased by 114.3% year-over-year, from 46.4% to -6.6%.
What is the long-term trend for Novavax's earnings yield?: Over 5 years (2020 to 2025), Novavax's earnings yield has grown at a 52.1% compound annual growth rate (CAGR), from -5% to 40.3%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.